Literature DB >> 16183524

Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract.

Günter Klöppel1, Martin Anlauf.   

Abstract

The diffuse neuroendocrine cell gives rise to a heterogeneous population of tumours which differ in their morphological and functional features. The term 'carcinoid', although well established in medical terminology, is therefore no longer adequate to cover the entire spectrum of neuroendocrine neoplasms. Here we use the term neuroendocrine tumours (NET), which was suggested in the WHO classification of 2000, and review the most important NET entities that are currently recognised in the gastrointestinal tract, highlighting their distinguishing features.

Entities:  

Mesh:

Year:  2005        PMID: 16183524     DOI: 10.1016/j.bpg.2005.02.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  38 in total

Review 1.  Sunitinib in pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Pascal Hammel; Chantal Dreyer; Christian Maatescu; Olivia Hentic; Philippe Ruszniewski; Sandrine Faivre
Journal:  Target Oncol       Date:  2012-06-02       Impact factor: 4.493

2.  Mixed exocrine and endocrine carcinoma in the stomach: a case report.

Authors:  Han Hong Lee; Chan Kwon Jung; Eun Sun Jung; Kyo Young Song; Hae Myung Jeon; Cho Hyun Park
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

3.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

4.  Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006.

Authors:  Osama Qubaiah; Susan S Devesa; Charles E Platz; Mark M Huycke; Graça M Dores
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

5.  18F-DOPA PET/CT and neuroendocrine tumours.

Authors:  Cristina Nanni; Domenico Rubello; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05       Impact factor: 9.236

Review 6.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.

Authors:  Ashok R Gunawardene; Bernard M Corfe; Carolyn A Staton
Journal:  Int J Exp Pathol       Date:  2011-04-25       Impact factor: 1.925

Review 7.  Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.

Authors:  Tarun Rustagi; Mridula Rai; Frank Bauer
Journal:  J Gastrointest Cancer       Date:  2013-09

8.  The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors.

Authors:  Xiaochuan Guo; Zhiyuan Mao; Dan Su; Zhaocai Jiang; Li Bai
Journal:  Med Oncol       Date:  2014-03-18       Impact factor: 3.064

Review 9.  Practical management and treatment of pancreatic neuroendocrine tumors.

Authors:  Naoko Iwahashi Kondo; Yasuharu Ikeda
Journal:  Gland Surg       Date:  2014-11

10.  Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.

Authors:  Matthias Banasch; Frank Schmitz
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.